Indeed, therapeutic supplementation of recombinant BMP4 protein or restoring the expression of BMP4 sensitized the breast cancer cells to anoikis and significantly decreased the volume of circulating cancer cells with subsequent inhibition of metastatic niches to the bones and lungs [96]. The gene discussed is BMP4; the disease is breast cancer.